Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

METROPOLIS HEALTHCARE LTD.

NSE : METROPOLISBSE : 542650ISIN CODE : INE112L01020Industry : Hospital & Healthcare ServicesHouse : Metropolis

BSE1773.9038.8 (+2.24 %)

PREV CLOSE ( ) 1735.10

OPEN PRICE ( ) 1736.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4227

TODAY'S LOW / HIGH ( )1736.30 1785.00

52 WK LOW / HIGH ( )1383.7 2306.85

NSE1773.3035.4 (+2.04 %)

PREV CLOSE( ) 1737.90

OPEN PRICE ( ) 1739.90

BID PRICE (QTY) 1773.30 (80)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 90492

TODAY'S LOW / HIGH( ) 1735.10 1789.90

52 WK LOW / HIGH ( )1315 2318.3

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-11 2000

Management Info

Sushil Shah - Chairman Surendran Chemmenkotil - Managing Director

Registered Office

Address 4th Floor, East Wing, Plot-254 B,Nirlon House, Dr. Annie Besant Road,Worli,
Mumbai,
Maharashtra-400030

Phone 022 6258 2810 / 8422 801 801

Email support@metropolisindia.com / secretarial@metropolisindia.com

Website www.metropolisindia.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

02Jul Metropolis Healthcare informs about di
Metropolis Healthcare has informed that it enclosed disclosure under Reg..

20Jun Announcement under Regulation 30 (LOD
Appointment of Dr. Monika Prabhakar as Group Head - Lab Operations

18Jun Metropolis Healthcare rises as its arm
Metropolis Healthcare is currently trading at Rs. 1699.05, up by 6.85 po..

17Jun Metropolis Healthcare’s arm acquires e
Metropolis Healthcare’s subsidiary -- Scientific Metropolis Pathology ha..

17Jun Metropolis Healthcare informs about up
In continuation to intimation dated May 31, 2025, Metropolis Healthcare..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	238.5	1247.97
Gross Profit	286.34	1620.24
Operating Profit	603.36	2851.73
Net Sales	3119.53	12165.43

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kovai Medical Center (BSE) 6130.35 (3.04%)	M.Cap ( in Cr)6707.99
Dr. Lal Pathlabs (BSE) 2849.45 (3.44%)	M.Cap ( in Cr)23871.41
Jupiter Life Line (BSE) 1508.90 (1.27%)	M.Cap ( in Cr)9893.26
HealthcareGlobal (BSE) 566.40 (3.41%)	M.Cap ( in Cr)7896.49
Vijaya Diagnostic (BSE) 1020.05 (1.70%)	M.Cap ( in Cr)10474.60

Shareholding Pattern

	PROMOTERS	48.89%
	MUTUAL FUNDS/UTI	26.42%
	NON-INSTITUTION	5.52%
	FI/BANKS/INSURANCE	3.75%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
NJ ELSS Tax Saver S...	3.25
HDFC Pharma and Hea...	2.26
LIC MF Healthcare F...	2.22
UTI Healthcare Fund...	1.55
HDFC Focused Fund-Reg(G)	1.54
Tata Business Cycle...	1.44
Baroda BNP Paribas ...	1.35

Risk Disclosures on Derivatives

Smart Quotes

METROPOLIS HEALTHCARE LTD.